Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company opera…
Medical - Instruments & Supplies
US, South Jordan [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -1.87 | 67.32 | 68.61 | |
| Graham Fair Price | 4.49 | 15.32 | 14.66 | |
| PEG | 1272.18 | 18.50 | 1.35 | |
| Price/Book | 8.46 | 3.51 | 3.24 | |
| Price/Cash Flow | 96.24 | 183.94 | 93.73 | |
| Prices/Earnings | 0.05 | 38.55 | 38.53 | |
| Price/Sales | 6.57 | 13.46 | 12.63 | |
| Price/FCF | 96.24 | 183.94 | 93.73 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 3.96 | 0.47 | 0.45 | |
| Operating Margin | -0.38 | 0.11 | 0.11 | |
| ROA | -15.02 | 0.01 | 0.01 | |
| ROE | 0.02 | 0.02 | 8.41 | |
| ROIC | 0.02 | 0.01 | -23.01 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.02 | -0.13 | 83.61 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.22 | 0.10 | -55.88 | |
| EPS QOQ | 0.29 | 0.02 | -92.71 | |
| FCF QOQ | 2.60 | -0.57 | -78.29 | |
| Revenue QOQ | -0.02 | < 0.005 | -95.43 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Bad
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 158.08 | 158.60 | 0.33 | |
| Days Sales Outstanding (DSO) | 54.48 | 53.44 | -1.91 | |
| Inventory Turnover | 0.57 | 0.57 | -0.33 | |
| Debt/Capitalization | 0.22 | 0.41 | 84.30 | |
| Quick Ratio | 1.33 | 4.23 | 217.10 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 21.32 | 21.40 | 0.36 | |
| Cash | 1.02 | 10.06 | 889.03 | |
| Capex | -0.15 | -0.22 | -45.24 | |
| Free Cash Flow | 0.74 | 0.41 | -44.53 | |
| Revenue | 5.46 | 5.58 | 2.14 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Positive
Fundamentals
Financial Health
06 - Financial Health ·
Bad